The reply to the correspondence entitled “Understanding HBcrAg components helps the better interpretation of clinical HBcrAg assay results” by Hong, X. and Hu, J.

We thank Hong and Hu [1] for their interest in our article [2] and we also thank the Journal of Hepatology for the opportunity to reply to their thoughtful discussion on the nature of HBcrAg. We appreciate them for their questions, but the discussion does not influence on our major conclusion that the novel high-sensitivity HBcrAg quantitative assay, iTACT-HBcrAg, could be useful to monitor responses in HBeAg-negative patients and detect HBV reactivation.

Source: Journal of Hepatology - July 8, 2021 Category: Gastroenterology Authors: Takako Inoue, Shintaro Yagi, Yasuhito Tanaka Tags: Letter to the Editor Source Type: research